You are here

Kategorie: Medicine Wellness Health

Medicine Wellness Health 

Asahi Kasei Microdevices Showcases AgeTech and PetTech Solutions Combining Privacy and Convenience at CES® 2026

PR-Gateway

TOKYO – November 13, 2025 – Asahi Kasei Microdevices Corporation (AKM) will showcase its latest sensing technologies for the growing AgeTech and PetTech markets at CES® 2026. The demonstrations, featuring technologies such as millimeter-wave radar and energy-harvesting innovations, will be presented in the Digital Health section of the Venetian Expo at booth 54829. With aging populations driving increased demand for safety and wellness solutions, AKM is focusing on technologies that address real-world health and caregiving challenges. According to the U.S. Centers for Disease Control and Prevention (CDC), one in four…

Mehr...
Medicine Wellness Health 

Asahi Kasei Elevates Critical Care Solutions with FDA Approval of ZOLL“s Zenix Monitor/Defibrillator

PR-Gateway

Chelmsford, MA; Novi, MI; Düsseldorf, Germany; and Tokyo, Japan – October 9, 2025 – Asahi Kasei, a global provider of healthcare technology and pharmaceutical solutions, has advanced its suite of critical care products through premarket approval by the U.S. Food and Drug Administration (FDA) for ZOLL“s Zenix® monitor/defibrillator. The Zenix device is the culmination of years of user feedback and is ZOLL“s most clinically advanced, user-friendly professional monitor/defibrillator. Asahi Kasei“s critical care lineup under ZOLL® is a key growth driver supporting long-term corporate development. The Zenix monitor/defibrillator is designed for…

Mehr...
Medicine Wellness Health 

Asahi Kasei Elevates Critical Care Solutions with FDA Approval of ZOLL“s Zenix Monitor/Defibrillator

PR-Gateway

Chelmsford, MA; Novi, MI; Düsseldorf, Germany; and Tokyo, Japan – October 9, 2025 – Asahi Kasei, a global provider of healthcare technology and pharmaceutical solutions, has advanced its suite of critical care products through premarket approval by the U.S. Food and Drug Administration (FDA) for ZOLL“s Zenix® monitor/defibrillator. The Zenix device is the culmination of years of user feedback and is ZOLL“s most clinically advanced, user-friendly professional monitor/defibrillator. Asahi Kasei“s critical care lineup under ZOLL® is a key growth driver supporting long-term corporate development. The Zenix monitor/defibrillator is designed for…

Mehr...
Medicine Wellness Health 

Asahi Kasei Elevates Critical Care Solutions with FDA Approval of ZOLL“s Zenix Monitor/Defibrillator

PR-Gateway

Chelmsford, MA; Novi, MI; Düsseldorf, Germany; and Tokyo, Japan – October 9, 2025 – Asahi Kasei, a global provider of healthcare technology and pharmaceutical solutions, has advanced its suite of critical care products through premarket approval by the U.S. Food and Drug Administration (FDA) for ZOLL“s Zenix® monitor/defibrillator. The Zenix device is the culmination of years of user feedback and is ZOLL“s most clinically advanced, user-friendly professional monitor/defibrillator. Asahi Kasei“s critical care lineup under ZOLL® is a key growth driver supporting long-term corporate development. The Zenix monitor/defibrillator is designed for…

Mehr...
Medicine Wellness Health 

Asahi Kasei Expands Healthcare Materials Portfolio with Sonanos™ Next-Generation Excipients

PR-Gateway

DUESSELDORF, Germany, Tokyo, and Novi, Michigan – October 9, 2025 – Asahi Kasei, a trusted provider in healthcare materials and technology, announced that it will launch two new specialty grades in its Sonanos™ portfolio. Paid samples are already available, and products manufactured in compliance with Good Manufacturing Practice (GMP) are scheduled for sale in 2027. Sonanos™ is a next-generation excipient designed to improve the formulation of injectable drugs. This aligns with the company“s long-term growth strategy to enhance its presence in the fast-growing pharmaceutical materials market. Global demand for biologics,…

Mehr...
Medicine Wellness Health 

LEONARDO® Dual 20 Laser: The art of combining 1470 nm and 1940 nm for optimal water absorption

PR-Gateway

The new LEONARDO® Dual 20 Laser from biolitec® for endovenous laser therapy enables optimal adjustment of water absorption through individual combination of the wavelengths 1470 nm and 1940 nm for all relevant treatment situations on the leg Jena, September 23, 2025 – The new LEONARDO® Dual 20 laser from biolitec® for endovenous laser therapy enables refinement of the art of ensuring the correct penetration depth with optimal water absorption by combining the wavelengths 1470 nm and 1940 nm. With this laser, biolitec® sets new standards in precision, tissue preservation, and…

Mehr...
Medicine Wellness Health 

Bionova Scientific opens new pDNA facility in Texas to support rapidly growing biopharma industry

PR-Gateway

DUESSELDORF, Germany, and NOVI, Mich. – August 12, 2025 – Bionova Scientific, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary of global conglomerate Asahi Kasei, has announced the opening of a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas. Located less than 30 miles north of Houston, Texas, the new facility designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. With the global pharmaceutical market anticipated to reach almost $3 trillion by 2033, Bionova Scientific…

Mehr...
Medicine Wellness Health 

Asahi Kasei Expands Planova™ Production with New Spinning Plant

PR-Gateway

Strengthening Life Science“s Global Bioprocess Supply Capabilities DÜSSELDORF, Germany & CHELMSFORD, Mass. & NOVI, Mich. & TOKYO – July 29, 2025 – Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova™ virus removal filters in Nobeoka City, Miyazaki, Japan. The new facility will be the company“s fourth spinning plant for hollow-fiber cellulose membrane filters. Construction is scheduled to begin in July 2026, with operations starting in January 2030. The initiative, backed by a grant from Japan“s…

Mehr...
Medicine Wellness Health 

New LEONARDO® Duster laser for lithotripsy, prostatic hyperplasia and other urological disorders receives FDA approval

PR-Gateway, ,

biolitec® announces the launch of its new LEONARDO® Duster Super Pulsed Thulium Fiber Laser, which has now received FDA approval and will improve laser-based treatment in urology, providing unparalleled precision, efficiency and versatility in urological applications Jena, 17.07.2025 – biolitec® is pleased to announce the launch of the LEONARDO® Duster Super Pulsed Thulium Fiber Laser (TFL), a significant advancement in urology laser technology. This innovative laser has received FDA approval (14.07.2025), marking a major milestone in the biolitec® LEONARDO® laser portfolio. The LEONARDO® Duster is designed for a range of…

Mehr...

Asahi Kasei Pharma starts Phase III study of promising CIPN prevention therapy, ART-123 (Recomodulin™), to enhance treatment options worldwide

PR-Gateway

Chelmsford, MA; Novi, MI; Düsseldorf, Germany; and Tokyo, Japan – July 2, 2025 – Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan (generic name: thrombomodulin alfa; marketed as Recomodulin™ Injection in Japan) for the prevention of chemotherapy-induced peripheral neuropathy (CIPN) related symptoms. This announcement follows encouraging data from earlier Phase I and II studies performed in Japan on the efficacy of ART-123 in relieving patient symptoms without compromising existing treatment plans. Chemotherapies such as platinum-based drugs, taxanes, and vinca alkaloids are…

Mehr...